Publication:
Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery

dc.contributor.authorLebrón, José Antonio
dc.contributor.authorLópez-López, Manuel
dc.contributor.authorGarcía-Calderón, Clara B.
dc.contributor.authorV. Rosado, Ivan
dc.contributor.authorBalestra, Fernando R.
dc.contributor.authorHuertas, Pablo
dc.contributor.authorRodik, Roman V.
dc.contributor.authorKalchenko, Vitaly I.
dc.contributor.authorBernal, Eva
dc.contributor.authorMoyá, María Luisa
dc.contributor.authorLópez-Cornejo, Pilar
dc.contributor.authorOstos, Francisco J.
dc.contributor.authoraffiliation[Lebrón,JA; Bernal,E; Moyá,ML; López-Cornejo,P; Ostos,FJ] Department of Physical Chemistry, Faculty of Chemistry, University of Seville, Seville, Spain. [López-López,M] Department of Chemical Engineering, Physical Chemistry and Materials Science, Faculty of Experimental Sciences, University of Huelva, Huelva, Spain. [García-Calderón,CB; V. Rosado,I] Institute of Biomedicine of Seville (IBiS), University Hospital Virgen del Rocío/CSIC/University of Seville, Seville, Spain. [Balestra,FR; Huertas,P] Department of Genetics, Faculty of Biology, University of Seville, Seville, Spain. [Balestra,FR; Huertas,P] Andalusian Center of Molecular Biology and Regenerative Medicine (CABIMER), University of Seville-CSIC-University Pablo de Olavide, Seville, Spain. [Rodik,RV; Kalchenko,VI] Institute of Organic Chemistry, National Academy of Science of Ukraine, Kiev, Ukraine.
dc.contributor.funderThis work was financed by the Consejería de Conocimiento, Innovación y Universidades de la Junta de Andalucía (FQM-206, FQM-274, and PY20-01234), the VI Plan Propio Universidad de Sevilla (PP2019/00000748), RTI2018-100692-B-100; P18-RT-1271; PI18-0005-2018; VI-PP AY.SUPLEM 2019; RYC-2015-18670, The R+D+I grant PID2019-104195G from the Spanish Ministry of Science and Innovation-Agencia Estatal de investigación/10.13039/501100011033 (P.H.) and the European Union (Feder Funds). The authors thank the University of Seville for the grant VPPI-US. J.A.L. also thanks the Fundación ONCE funded by the Fondo Social Europeo.
dc.date.accessioned2022-07-26T10:55:43Z
dc.date.available2022-07-26T10:55:43Z
dc.date.issued2021-08-12
dc.description.abstractThe formation of calixarene-based liposomes was investigated, and the characterization of these nanostructures was carried out using several techniques. Four amphiphilic calixarenes were used. The length of the hydrophobic chains attached to the lower rim as well as the nature of the polar group present in the upper rim of the calixarenes were varied. The lipid bilayer was formed with one calixarene and with the phospholipid 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine, DOPE. The cytotoxicity of the liposomes for various cell lines was also studied. From the results obtained, the liposomes formed with the least cytotoxic calixarene, (TEAC12)4, were used as nanocarriers of both nucleic acids and the antineoplastic drug doxorubicin, DOX. Results showed that (TEAC12)4/DOPE/p-EGFP-C1 lipoplexes, of a given composition, can transfect the genetic material, although the transfection efficiency substantially increases in the presence of an additional amount of DOPE as coadjuvant. On the other hand, the (TEAC12)4/DOPE liposomes present a high doxorubicin encapsulation efficiency, and a slow controlled release, which could diminish the side effects of the drug.es_ES
dc.description.versionYeses_ES
dc.identifier.citationLebrón JA, López-López M, García-Calderón CB, V Rosado I, Balestra FR, Huertas P, et al. Multivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Delivery. Pharmaceutics. 2021 Aug 12;13(8):1250es_ES
dc.identifier.doi10.3390/pharmaceutics13081250es_ES
dc.identifier.essn1999-4923
dc.identifier.pmcPMC8398082
dc.identifier.pmid34452211es_ES
dc.identifier.urihttp://hdl.handle.net/10668/3826
dc.journal.titlePharmaceutics
dc.language.isoen
dc.page.number26 p.
dc.publisherMDPIes_ES
dc.relation.publisherversionhttps://www.mdpi.com/1999-4923/13/8/1250/htmes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rightsAtribución 4.0 Internacional*
dc.rightsAtribución 4.0 Internacional*
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectCationic calix[4]areneses_ES
dc.subjectLiposomeses_ES
dc.subjectNucleic acidses_ES
dc.subjectTransfection efficiencyes_ES
dc.subjectDoxorubicines_ES
dc.subjectEncapsulationes_ES
dc.subjectLiposomases_ES
dc.subjectÁcidos nucleicoses_ES
dc.subjectDoxorrubicinaes_ES
dc.subjectEncapsulación celulares_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Biomedical and Dental Materials::Membranes, Artificial::Liposomeses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Polycyclic Compounds::Macrocyclic Compounds::Calixareneses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Pharmaceutical Preparations::Dosage Forms::Delayed-Action Preparationses_ES
dc.subject.meshMedical Subject Headings::Analytical, Diagnostic and Therapeutic Techniques and Equipment::Investigative Techniques::Genetic Techniques::Gene Transfer Techniques::Transfectiones_ES
dc.subject.meshMedical Subject Headings::Anatomy::Cells::Cells, Cultured::Cell Linees_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Organic Chemicals::Hydrocarbons::Hydrocarbons, Cyclic::Hydrocarbons, Aromatic::Polycyclic Hydrocarbons, Aromatic::Naphthacenes::Anthracyclines::Daunorubicin::Doxorubicines_ES
dc.subject.meshMedical Subject Headings::Technology and Food and Beverages::Technology, Industry, and Agriculture::Manufactured Materials::Nanostructureses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Chemical Actions and Uses::Pharmacologic Actions::Therapeutic Uses::Antineoplastic Agentses_ES
dc.subject.meshMedical Subject Headings::Chemicals and Drugs::Nucleic Acids, Nucleotides, and Nucleosides::Nucleic Acidses_ES
dc.titleMultivalent Calixarene-Based Liposomes as Platforms for Gene and Drug Deliveryes_ES
dc.typeresearch article
dc.type.hasVersionVoR
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 2 of 2
Loading...
Thumbnail Image
Name:
Lebron_MultivalentCalixarene.pdf
Size:
7.74 MB
Format:
Adobe Portable Document Format
Description:
Artículo original
Loading...
Thumbnail Image
Name:
Lebron_MultivalentCalixarene_MaterialSuplementario.pdf
Size:
956.46 KB
Format:
Adobe Portable Document Format
Description:
Material suplementario